Hypertensive disease
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral
Vasospastic Angina
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral
Anginal Pain
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral
Homozygous Familial Hypercholesterolemia
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral
Cardiovascular Events
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral
angiographically documented disease
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral
inadequate response to diet
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral
Primary Hypercholesterolemia
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral
Pharmacotherapy
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral
Heart failure
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral
High Cardiovascular Risk
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral
Hypertensive disease
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral
Mixed Dyslipidaemia
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral
Lifestyle Modification
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral
inadequate control on monotherapy
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral
Dyslipidemias
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral
Chronic Stable Angina Pectoris
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral
Coronary Artery Disease (CAD)
, 5.0 mg, 10.0 mg, 2.5 mg, 1.0 mg/mL
Tablet, film coated, Tablet, , Tablet - Oral, Oral, Capsule, Tablet, film coated - Oral, Tablet, coated, Tablet, multilayer - Oral, Capsule - Oral, Kit, Suspension - Oral, Solution, Tablet, coated - Oral, Suspension, Tablet, multilayer, Solution - Oral